Skip to content

Deep Brain Stimulation of subthalamic nucleus to treat Meige Syndrome: registry study

Deep Brain Stimulation of subthalamic nucleus to treat Meige Syndrome: registry study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OOC-17011684
Enrollment
Unknown
Registered
2017-06-17
Start date
2017-06-17
Completion date
Unknown
Last updated
2017-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meige syndrome

Interventions

Sponsors

Aviation General Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The diagnosis of idiopathic cranial facial focal or segmental dystonia, including simple blepharospasm or oromandibular dystonia patients, as well as other parts of the muscle of any of the above symptoms involving the craniofacial; 2. Patients who have failed to effectively control symptoms and / or have been treated with oral botulinum toxin for at least 6 months, and who have severe impact on their quality of life, are required to undergo surgical treatment; 3. Except for symptoms of dystonia, the body is in good health; 4. The MMSE showed normal screening results; 5. The subjects or their families can fully understand the treatment and sign informed consent; 6. The subjects with good compliance, can be required to complete the follow-up after operation.

Exclusion criteria

Exclusion criteria: 1. Imaging findings of patients with abnormal basal ganglia; 2. Patients suffer from severe progressive neurological, cardiovascular, respiratory, or digestive diseases; 3. The patient's mental state is unstable; 4. Patients with contraindications to surgery or anesthesia, such as long-term use of anticoagulant, antiplatelet drugs; 5. Female patients who are planning to conceive or are pregnant and lactating women. 6. The patients have or need other implantable devices, such as pacemakers, defibrillators, cochlear and spinal nerve stimulator; 7. The patients need do repeated MRI because of their own reasons during clinical trials in the future; 8. The patients have participated in other clinical trials.

Design outcomes

Primary

MeasureTime frame
BFMDRS scale;

Secondary

MeasureTime frame
SF-36 scale;Score of HAMD;Score of YALE-BROWN;Cognitive Tests;

Countries

China

Contacts

Public ContactLin Wang

Aviation General Hospital of China Medical University

wanglin70321@126.com+86 15810362938

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026